Abstract
Surgical aortic valve replacement is the gold standard therapy for severe aortic stenosis but transcatheter aortic valve implantation (TAVI) is increasingly employed in "high-risk" patients. Atrioventricular block and aortic regurgitation are frequent complications of nitinol-based stented valves. We report a case of successful, but complex reoperative surgery 13 days after failed TAVI with iatrogenic aortic and mitral regurgitation and new-onset heart block. Removal of a CoreValve prosthesis (Medtronic Inc, Minneapolis, MN) with standard aortic valve replacement resulted in restoration of sinus rhythm and valvular competencies.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
MeSH terms
-
Aged, 80 and over
-
Aortic Valve Insufficiency / diagnostic imaging
-
Aortic Valve Insufficiency / etiology
-
Aortic Valve Insufficiency / surgery*
-
Aortic Valve Stenosis / diagnostic imaging
-
Aortic Valve Stenosis / surgery
-
Atrioventricular Block / etiology*
-
Atrioventricular Block / physiopathology
-
Device Removal / methods
-
Echocardiography, Doppler / methods
-
Echocardiography, Transesophageal / methods
-
Heart Valve Prosthesis
-
Humans
-
Iatrogenic Disease*
-
Male
-
Mitral Valve Insufficiency / diagnostic imaging
-
Mitral Valve Insufficiency / etiology
-
Mitral Valve Insufficiency / surgery*
-
Prosthesis Failure
-
Reoperation / methods
-
Risk Assessment
-
Severity of Illness Index
-
Transcatheter Aortic Valve Replacement / adverse effects*
-
Transcatheter Aortic Valve Replacement / methods
-
Treatment Outcome